CHIP at a VAF of 10% or greater is the strongest predictor of whether daily low-dose aspirin can help prevent cancer in healthy, older adults.

Opioid-naïve adults receiving spinal manipulative therapy for low back pain were less likely to develop OUD vs those prescribed ibuprofen.

Disease activity and multimorbidity among patients in the US with PsA varied based on geographic region, socioeconomic deprivation, race, and gender.

Early and surgical menopause were associated with an increased risk for labor market exit compared with natural menopause.

Mothers of children with active atopic dermatitis had higher Edinburgh Postnatal Depression Scale scores after adjustment.

Bone-related biomarkers, including osteocalcin and CTX, were generally not associated with hip fracture risk among postmenopausal women.

Pregnant patients with heart failure should receive counseling, specialist treatment, and appropriate fetal heart monitoring.

The Food and Drug Administration has granted Breakthrough Therapy designation to CD388 for seasonal influenza prevention.

Upadacitinib and secukinumab for PsA offers comparable improvements in skin and joint symptoms, but adalimumab offers superior pain relief.

Treatment with HCQ vs standard therapy alone was linked to higher live birth rates and fewer obstetric complications among pregnant women with APS.

Greater disease activity and higher proteinuria levels were associated with a greater risk for VTE among patients with LN.

The Food and Drug Administration has approved Enoby, a biosimilar to Prolia, and Xtrenbo, a biosimilar to Xgeva.